Abstract:Aim and Objective: 4-Hydroxyphenylpyruvate dioxygenase (HPPD), converting p-hydroxyphenylpyruvate (HPPA) to homogentisate (HGA), is an important target for treating type I tyrosinemia and synthesizing novel herbicides due to its significant role in tyrosine catabolism. Hence, it is imperative to design novel HPPD inhibitors that can block HPPA-HGA conversion, which leads to the deficiency in isoprenoid redox cofactors such as plastoquinone and tocopherol, and finally caused growth inhibition. This study was undertaken to investigate structural requirements for their HPPD inhibition with better biological activity. Materials and Methods: Based on the structure-activity relationships, a series of quinolinone-2,4-diones derivatives were studied using combined of 2D multiple linear regression (2D-MLR) and 3D quantitative structure-activity relationship (3D-QSAR). Firstly, genetic algorithm (GA) was applied and descriptors generated in DRAGON 5.5 software were used for building 2D-MLR models in the QSARINGS. Then CoMFA and CoMSIA models were performed by using alignment of the common framework and the pharmacophore model. The obtained models were validated through internal and external validation to verify predictive abilities. Especially, the CoMFA and CoMSIA contour maps were used to show vital structural characteristics related to HPPD inhibitors activities. Results: The 2D-MLR liner equation and corresponding parameters were listed as follows: pK(i) = -38.2034Me+22.4078GATS2m-1.4265EEig15r-2.1849Hy+32.9158 n(tr)= 28, n(pred)=6, R-2 = 0.863, Q(2) (LOO)=0.787, Q(2) (LMO)=0.607, Q(2) (F1)=0.780, Q(2) (F2)=0.780, Q(2) (F3)=0.860, CCCpred=0.920. RMSEtr=0.253, RMSEpred=0.555, F=36.289 The steric contours graph indicated that small and negative electrostatic substitutions at R-1 and R2 regions were favorable for the better activity, and hydrogen-bond donors at this region would also increase the activity. Positive electrostatic and bulky substitutions in the R-3 position would enhance the activity. The analysis of these models suggested that the steric factor of R-4 position was crucial for activity of quinazoline-2,4-diones HPPD inhibitors, bulky substitutions might improve the bioactivity of these inhibitors greatly, meanwhile, hydrogen-bond acceptor groups in this position were required for higher activity. Conclusion: In this study, a combined 2D-MLR, CoMFA and CoMSIA models demonstrated satisfying results through internal and external validation, especially good predictive abilities and the CoMFA and CoMSIA contour maps showed vital structural characteristics related to HPPD inhibitors activities.

Quantitative structure-activity relationships for phenyl triazolinones of protoporphyrinogen oxidase inhibitors: a density functional theory study.

A DFT-based QSARs Study of Protoporphyrinogen Oxidase Inhibitors: Phenyl Triazolinones

Quantitative Structure-Activity Relationships of 1,3,4-Thiadiazol-2(3h)-ones and 1,3,4-Oxadiazol-2(3h)-ones As Human Protoporphyrinogen Oxidase Inhibitors

Synthesis, Crystal Structures, Fluorescence and Xanthine Oxidase Inhibitory Activity of Pyrazole-Based 1,3,4-Oxadiazole Derivatives

Structure–activity relationships of diphenyl-ether as protoporphyrinogen oxidase inhibitors: insights from computational simulations

Hexahydrophthalimide–benzothiazole Hybrids As a New Class of Protoporphyrinogen Oxidase Inhibitors: Synthesis, Structure–activity Relationship, and DFT Calculations

Bioactive Conformation Analysis of Cyclic Imides As Protoporphyrinogen Oxidase Inhibitor by Combining DFT Calculations, QSAR and Molecular Dynamic Simulations

Insight into the structural requirements of protoporphyrinogen oxidase inhibitors: Molecular docking and CoMFA of diphenyl ether, isoxazole phenyl, and pyrazole phenyl ether

Design, Synthesis, and Molecular Simulation Studies of N-phenyltetrahydroquinazolinones As Protoporphyrinogen IX Oxidase Inhibitors.

Design, Synthesis, and 3D-QSAR Analysis of Novel 1,3,4-Oxadiazol-2(3h)-ones As Protoporphyrinogen Oxidase Inhibitors

Design, Synthesis, and Metabolism Studies of N-1,4-Diketophenyltriazinones As Protoporphyrinogen IX Oxidase Inhibitors.

Design, Syntheses and 3D-QSAR Studies of Novel N-phenyl Pyrrolidin-2-ones and N-phenyl-1H-pyrrol-2-ones As Protoporphyrinogen Oxidase Inhibitors

Design, Synthesis, and Biological Activity of Novel Phenyltriazolinone PPO Inhibitors Containing Five-Membered Heterocycles

Quantitative Structure Activity Relationship Studies and Molecular Dynamics Simulations of 2-(Aryloxyacetyl)cyclohexane-1,3-diones Derivatives As 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors

Synthesis and Protoporphyrinogen Oxidase Activity Inhibition of 3-(4-chloro-2-fluoro-5-substituent-phenyl)-7-methyl-3h-pyrazolo[3,4-d] [1,2,3]Triazin-4(7H)-ones

New Research for Quinazoline-2,4-diones as HPPD Inhibitors Based on 2D-MLR and 3D-QSAR Models.

Novel Phenoxy-(Trifluoromethyl)pyridine-2-pyrrolidinone-based Inhibitors of Protoporphyrinogen Oxidase: Design, Synthesis, and Herbicidal Activity.

Rational Prediction of the Herbicidal Activities of Novel Protoporphyrinogen Oxidase Inhibitors by Quantitative Structure-Activity Relationship Model Based on Docking-Guided Active Conformation

Design, Synthesis, and Molecular Mechanism Studies of <i>N</i>-Phenylisoxazoline-thiadiazolo[3,4-<i>a</i>]pyridazine Hybrids as Protoporphyrinogen IX Oxidase Inhibitors

Noncovalent interactions between quinoxalines and protoporphyrinogen oxidase (PPO): a computational case study for herbicidal applications

Synthesis and Biological Activity Evaluation of Benzoxazinone-Pyrimidinedione Hybrids as Potent Protoporphyrinogen IX Oxidase Inhibitor